The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research.
Malvern, US
Size (employees)
938 (est)
BioTelemetry was founded in 2013 and is headquartered in Malvern, US

BioTelemetry Office Locations

BioTelemetry has an office in Malvern
Malvern, US (HQ)
102 1000 Cedar Hollow Rd

BioTelemetry Data and Metrics

BioTelemetry Financial Metrics

BioTelemetry's revenue was reported to be $55.9 m in Q1, 2017

Revenue (Q1, 2017)

55.9 m

Gross profit (Q1, 2017)

32.9 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

196 k

EBIT (Q1, 2017)

2.3 m

Market capitalization (19-Sep-2017)

948.6 m

Cash (31-Mar-2017)

25.1 m
BioTelemetry's current market capitalization is $948.6 m.
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


119 m111.5 m129.5 m166.6 m178.5 m208.3 m

Revenue growth, %


Cost of goods sold

6.2 m5.1 m4.9 m73.1 m72 m78.9 m

Gross profit

112.8 m106.4 m124.6 m93.5 m106.6 m129.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


42.7 m43.1 m43.4 m44.8 m43.5 m48.6 m52.7 m53.1 m55.9 m

Cost of goods sold

19 m19.4 m18.2 m18.1 m17.2 m18 m19.8 m20.2 m23 m

Gross profit

23.6 m23.7 m25.2 m26.7 m26.3 m30.6 m32.9 m32.9 m32.9 m

Gross profit Margin, %

USDY, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016


18.7 m18.3 m18.3 m22.2 m20 m19 m23.1 m


2.4 m2.4 m1.5 m5.2 m

Current Assets

44.3 m49.5 m47 m59.6 m


18.8 m21.7 m25.6 m25.8 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


13.5 m12.2 m12.3 m14.8 m15.5 m22.8 m25.4 m32.3 m25.1 m


3 m2.6 m3 m3.2 m2.8 m2.9 m3.5 m3.8 m4.3 m

Current Assets

41.8 m41.9 m42.3 m43.5 m45.2 m51.7 m59 m68.3 m64 m


29.1 m29 m21.4 m23.8 m25 m26.3 m26.3 m26.3 m26.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(7.3 m)(9.8 m)7.4 m53.4 m

Depreciation and Amortization

12.3 m12.6 m12.5 m14.3 m

Accounts Receivable

(4.6 m)(13 m)(7.7 m)


340 k299 k188 k(753 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(8.1 m)(8.1 m)(69 k)2.1 m4.6 m4 m8.3 m12.4 m196 k

Depreciation and Amortization

6 m9.2 m3 m6 m9.1 m3.3 m6.9 m10.6 m3.7 m

Accounts Receivable

(7.6 m)(11.2 m)(3 m)(4 m)(6.8 m)(2.9 m)


(104 k)307 k(456 k)(640 k)(241 k)(487 k)(786 k)(1.2 m)810 k
Y, 2017

Financial Leverage

1.4 x
Show all financial metrics

BioTelemetry Operating Metrics

FY, 2015FY, 2016

Patents (foreign)


Patents Issued




Patents (US)

Show all operating metrics

BioTelemetry Market Value History

Traffic Overview of BioTelemetry

BioTelemetry News and Updates

What the Fitbit lawsuit means for clinical researchers

 Fitbit is facing a class-action lawsuit regarding the accuracy of their heart-rate data, which have been shown to be inaccurate by a margin of up to 20 beats per minute. This news risks sending back to the drawing board many of us who have been experimenting with biotelemetry. Here we seek to prese…

BioTelemetry Company Life and Culture

You may also be interested in